Health Care: Drugs

Impax Laboratories Inc (IPXL: NASDAQ)

$48.54 0.25 | 0.52%
08/04/15 - 04:14 PM ET
Ratio Comparisons
Company Industry S&P 500
Valuation Ratios
P/E Ratio (TTM) 76.80 19.50 25.65
P/E High - Last 5 Yrs 40.80 26.10 42.96
P/E Low - Last 5 Yrs 0.00 12.60 11.15
Beta 1.33 0.22 1.09
Price to Sales (TTM) 5.58 4.26 2.96
Price to Book (MRQ) 3.87 4.94 5.58
Price to Tangible Book (MRQ) -446.83 -346.24 11.34
Price to Cash Flow (TTM) 43.10 14.20 19.07
Price to Free Cash Flow (TTM) -5.30 203.60 10.91
Dividends
Dividend Yield (%) 0.00 2.80 1.95
Dividend Yield - 5 Yr Avg (%) n.a. 3.60 2.37
Dividend 5 Yr Growth Rate (%) n.a. 5.52 17.01
Payout Ratio (TTM) 0.00 59.00 85.58
Sales (MRQ) vs Qtr 1 Yr Ago (%) 20.50 -6.30 0.23
Sales (TTM) vs TTM 1 Yr Ago (%) 16.50 -5.10 7.53
Growth Rates (%)
Sales - 5 Yr Growth Rate (%) -4.33 -1.65 6.51
EPS (MRQ) vs Qtr 1 Yr Ago (%) -100.00 111.90 19.87
EPS (TTM) vs TTM 1 Yr Ago (%) -100.00 111.90 19.87
EPS - 5 Yr Growth Rate (%) -22.65 -4.22 9.47
Capital Spending - 5 Yr Growth Rate (%) 33.91 -36.61 14.96
Financial Strength
Quick Ratio (MRQ) 1.40 1.20 1.26
Current Ratio (MRQ) 2.40 1.60 1.95
LT Debt to Equity (MRQ) 0.45 0.44 1.22
Total Debt to Equity (MRQ) 0.47 0.56 1.40
Interest Coverage (TTM) 18.20 21.60 46.35
Profitability Ratios (%)
Gross Margin (TTM) 56.40 76.70 47.74
Gross Margin - 5 Yr Avg 61.30 77.40 47.18
EBITD Margin (TTM) 18.30 27.30 25.90
EBITD - 5 Yr Avg 32.08 0.00 0.00
Pre-Tax Margin (TTM) 11.50 25.20 15.04
Pre-Tax Margin - 5 Yr Avg 26.40 20.80 14.86
Management Effectiveness (%)
Net Profit Margin (TTM) 7.20 19.67 8.68
Net Profit Margin - 5 Yr Avg 17.20 16.90 11.28
Return on Assets (TTM) 2.50 10.80 6.40
Return on Assets - 5 Yr Avg 12.00 7.90 6.59
Return on Investment (TTM) 3.40 18.10 11.91
Return on Investment - 5 Yr Avg 15.10 12.50 11.23
Efficiency
Revenue/Employee (TTM) 584,757.00 484,367.00 955,183.84
Net Income/Employee (TTM) 42,031.00 108,519.00 107,389.96
Receivable Turnover (TTM) 4.10 5.70 13.14
Inventory Turnover (TTM) 2.70 2.10 13.33
Asset Turnover (TTM) 0.40 0.50 0.76

Portfolios with IPXL

Latest IPXL Headlines from TheStreet

More Financial News for IPXL

Press Releases for IPXL

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter